نتایج جستجو برای: proliferative histiocytic disease

تعداد نتایج: 1516925  

2016
Guang-Zhi Yang Jing Li Lu-Ping Wang

BACKGROUND Xanthoma disseminatum (XD) is a rare benign histiocytic proliferating disease of non-Langerhans cell origin, which is clinically mainly characterized by cutaneous or mucous lesions. Although XD is acknowledged of one systematic disease, involvement of the central nervous system is quite rare. CASE PRESENTATION We presented one 34-year-old Chinese female with disseminated intracrani...

2016
Thaís Gimenez Miniello Juliane Piragine Araujo Norberto Nobuo Sugaya Fernando Melhem Elias Oslei Paes de Almeida Fabio Abreu Alves

Rosai-Dorfman disease (RDD), formerly called sinus histiocytosis with massive lymphadenopathy, is a non-neoplastic proliferative histiocytic disorder with behavior ranging from highly aggressive to spontaneous remission. Although the lymph nodes are more commonly involved, any organ can be affected. This study aimed to describe the features and the follow-up of a case of extranodal RDD. Our pat...

Journal: :Blood 1984
H J Weinstein E E Lack J R Cassady

Twenty-nine patients with biopsy-proven malignant lymphoma of large-cell "histiocytic" type were treated with the APO protocol (vincristine, adriamycin, and prednisone). Treatment consisted of two years of therapy with a modified adriamycin-containing acute lymphoblastic leukemia regimen with preventive cranial irradiation and regional radiotherapy (for patients with clinically localized lympho...

2014
Anna-Maria Bubolz Stephanie E. Weissinger Albrecht Stenzinger Annette Arndt Konrad Steinestel Silke Brüderlein Holger Cario Anneli Lubatschofski Claudia Welke Ioannis Anagnostopoulos Thomas F. E. Barth Ambros J. Beer Peter Möller Martin Gottstein Andreas Viardot Jochen K. Lennerz

For a growing number of tumors the BRAF V600E mutation carries therapeutic relevance. In histiocytic proliferations the distribution of BRAF mutations and their relevance has not been clarified. Here we present a retrospective genotyping study and a prospective observational study of a patient treated with a BRAF inhibitor. Genotyping of 69 histiocytic lesions revealed that 23/48 Langerhans cel...

Journal: :Blood 1980
C K Osborne L Norton R C Young A J Garvin R M Simon C W Berard S Hubbard V T DeVita

Nodular histiocytic lymphoma (NH) is uncommon, and its natural history is not well defined. Of 473 patients with non-Hodgkin's lymphoma, we found 16 (3.4%) with NH. Most patients (13/16) presented with pathologic stage (PS) III or IV disease, including 7 with liver involvement. One patient (PS III) was initially treated with cyclophosphamide alone, and 4 patients received only radiotherapy, and...

Journal: :Indian pediatrics 1994
B R Agarwal Z Currimbhoy

Histiocytic syndromes in children are divided into 3 classes: (i) Langerhans-cell histiocytosis (LCH) or Histiocytosis-X (HX), (ii) Hemophagocytic syndromes—Familial erythrophagocytic lymphohistiocytosis (FEL) and infection-associated hemophagocytic syndrome (IAHS) due to viruses (VAHS), and occasionally bacterial, fungal or parasitic, and (iii) Malignant histiocytic disorders(l). The lesional ...

2017
John L. Vaughn C. Eric Freitag Jessica A. Hemminger Jeffrey A. Jones

BACKGROUND Histiocytic sarcoma is a rare histiocytic neoplasm of unknown etiology that constitutes less than 1% of hematologic malignancies. A few cases of histiocytic sarcoma harboring the BRAF V600E mutation have been reported, but this finding has not been confirmed in all studies. CASE PRESENTATION We report the case of a 63-year-old white woman with a history of splenic marginal zone lym...

Journal: :The Journal of Bone and Joint Surgery. British volume 1956

Journal: :American Journal of Case Reports 2013

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید